UK markets open in 6 hours 10 minutes

Harvard Bioscience, Inc. (HBIO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.3000+0.0300 (+0.92%)
At close: 04:00PM EDT
3.3000 0.00 (0.00%)
After hours: 04:01PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
4,283
4,508
7,821
8,317
-
Total cash
4,283
4,508
7,821
8,317
-
Net receivables
16,099
16,705
21,834
17,766
-
Inventory
24,716
26,439
27,587
22,262
-
Other current assets
3,940
3,472
4,341
3,355
-
Total current assets
49,038
51,124
61,583
51,700
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
23,139
24,028
24,761
28,318
-
Accumulated depreciation
-14,385
-14,846
-14,449
-16,597
-
Net property, plant and equipment
8,754
9,182
10,312
11,721
-
Goodwill
57,065
56,260
57,689
58,590
-
Intangible assets
16,036
21,014
27,385
33,151
-
Other long-term assets
6,473
7,780
5,375
1,092
-
Total non-current assets
88,328
94,236
100,761
104,554
-
Total assets
137,366
145,360
162,344
156,254
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
5,859
3,811
3,235
1,721
-
Accounts payable
5,554
6,447
4,911
5,972
-
Taxes payable
-
0
224
286
609
Accrued liabilities
-
-
-
46
425
Deferred revenues
4,508
3,370
4,266
3,771
-
Other current liabilities
5,276
4,010
4,250
3,292
-
Total current liabilities
26,542
23,249
25,316
21,053
-
Non-current liabilities
Long-term debt
30,704
43,013
45,095
46,286
-
Deferred tax liabilities
776
590
1,558
1,899
-
Other long-term liabilities
1,476
1,006
486
2,854
-
Total non-current liabilities
37,750
49,891
53,627
58,520
-
Total liabilities
64,292
73,140
78,943
79,573
-
Stockholders' equity
Common stock
434
454
452
444
-
Retained earnings
-145,605
-142,190
-132,674
-132,386
-
Accumulated other comprehensive income
-14,190
-15,052
-10,027
-13,066
-
Total stockholders' equity
73,074
72,220
83,401
76,681
-
Total liabilities and stockholders' equity
137,366
145,360
162,344
156,254
-